- Founded in 2014
- Oostende, Belgie
- 51-200
- elicio.be
- linkedin.com/company/elicio
Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025
04 Feb
Sovereign Wealth Fund Institute
Read on ca.finance.yahoo.comElicio: Lymph Node Binding With ELI-002 Could Lead To Substantial H1 2025 Data
31 Jan
Sovereign Wealth Fund Institute
Read on seekingalpha.comElicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | Taiwan News | Jan. 30, 2025 21:00
30 Jan
Sovereign Wealth Fund Institute
Read on taiwannews.com.twElicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Elicio Therapeutics (NASDAQ:ELTX)
30 Jan
Sovereign Wealth Fund Institute
Read on benzinga.comElicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market ...
30 Jan
Sovereign Wealth Fund Institute
Read on eagletribune.comElicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy
22 Jan
Sovereign Wealth Fund Institute
Read on manilatimes.netElicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 | Business Upturn
12 Dec
Sovereign Wealth Fund Institute
Read on businessupturn.comElicio Therapeutics (ELTX) Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study
12 Dec
Sovereign Wealth Fund Institute
Read on streetinsider.comElicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 | Taiwan News | Dec. 12, 2024 20:00
12 Dec
Sovereign Wealth Fund Institute
Read on taiwannews.com.twElicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 - Elicio Therapeutics (NASDAQ:ELTX)
12 Dec
Sovereign Wealth Fund Institute
Read on benzinga.com